Patent · US Active

Elisa for a naturally-occurring soluble truncated form of IL-23 receptor

US9523073B2 · kind B2 · utility

0Cited by
0References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 31, 2011
Grant dateDec 20, 2016
Priority date
Expiry dateJul 5, 2032

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/368
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

A naturally-occurring soluble truncated IL-23Rα protein (i.e., Δ9 IL-23Rα) is shown to be present in a biological sample and can serve as a diagnostic tool for autoimmune diseases. There is provided an enzyme-linked immunosorbent assay (ELISA) and test kit for the serological detection of the soluble truncated form of IL-23Rα protein. More particularly, antibody-sandwich ELISA method and kits for Δ9 IL-23Rα as an antigen were developed to detect Δ9 IL-23Rα levels in biological samples from a mammal and a human patient and are used as a diagnostic index. The present disclosed ELISA has utility as a diagnostic tool to detect Crohn's disease in patients using EDTA-plasma.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.